Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-006035
Filing Date
2024-08-27
Accepted
2024-08-26 18:02:16
Documents
61
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 2024 stemtech_i10q-063024.htm   iXBRL 10-Q 766373
2 CERTIFICATION stemtech_ex3101.htm EX-31.1 11030
3 CERTIFICATION stemtech_ex3102.htm EX-31.2 10913
4 CERTIFICATION stemtech_ex3201.htm EX-32.1 4564
5 CERTIFICATION stemtech_ex3202.htm EX-32.2 4243
  Complete submission text file 0001683168-24-006035.txt   4928410

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE gntw-20240630.xsd EX-101.SCH 38580
7 XBRL CALCULATION FILE gntw-20240630_cal.xml EX-101.CAL 52797
8 XBRL DEFINITION FILE gntw-20240630_def.xml EX-101.DEF 140111
9 XBRL LABEL FILE gntw-20240630_lab.xml EX-101.LAB 342346
10 XBRL PRESENTATION FILE gntw-20240630_pre.xml EX-101.PRE 280907
63 EXTRACTED XBRL INSTANCE DOCUMENT stemtech_i10q-063024_htm.xml XML 587430
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (954) 715-6000
Stemtech Corp (Filer) CIK: 0001511820 (see all company filings)

EIN.: 872151440 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-172172 | Film No.: 241242720
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)